Trinity Biotech (TRIB) Non-cash Items (2009 - 2024)

Trinity Biotech (TRIB) has reported Non-cash Items for 16 consecutive years, with $7.0 million the latest figure, recorded in Q4 2024.

• Quarterly Non-cash Items rose 169.41% year-over-year to $7.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $9.6 million (up 70.2% YoY) and the FY2024 annual result came in at $2.5 million, up 874.71% from the prior year.
• Non-cash Items grew to $7.0 million in Q4 2024 per TRIB's latest filing, from -$2558.0 in the prior quarter.
• Over the last five years, Non-cash Items for TRIB reached as high as $14.8 million in Q4 2020 and fell as low as -$1.3 million in Q1 2022.
• A 5-year average of $3.0 million and a median of $2.3 million in 2020 frame the typical range for Non-cash Items.
• Annual changes were most pronounced in 2020 — Non-cash Items surged 449.09% — and 2023, when it sank 1592.66%.
• Year by year, Non-cash Items stood at $14.8 million in 2020, then plunged by 66.97% to $4.9 million in 2021, then slumped by 37.57% to $3.1 million in 2022, then retreated by 15.0% to $2.6 million in 2023, then soared by 169.41% to $7.0 million in 2024.
• According to Business Quant data, Non-cash Items over the past three periods registered $7.0 million, -$2558.0, and -$4052.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.